The atrial natriuretic peptide: A changing view

Journal of Hypertension

Volumn 19, Issue 11, 2001, Pages 1923-1931

  Rubattu, Speranza ^a,b   Volpe, Massimo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Atrial natriuretic peptide; Cardiovascular remodelling; Genetics of cardiovascular diseases; Salt water balance

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

CARDIOVASCULAR DISEASE; DISEASE MARKER; ELECTROLYTE BALANCE; HEART FAILURE; HOMEOSTASIS; HYPERTENSION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0034756422     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200111000-00001     Document Type: Review

References (97)

1. Natriuretic peptides
2. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats
3. Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide
4. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (α-hANP)
5. Molecular biology and biochemistry of the natriuretic peptide system
6. mRNA sequence for human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria
7. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor pro-hormone
8. Nucleotide sequences of the human and mouse atrial natriuretic factor genes
9. Cis-acting sequences that modulate atrial natriuretic factor gene expression
10. Proximal regulatory domains of rat atrial natriuretic factor gene
11. Upstream sequences confer atrial-specific expression of the human atrial natriuretic factor gene
12. Extra-atrial expression of the gene for atrial natriuretic factor
13. Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat
14. Isolation and structural analysis of 'urodilatin', a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine
15. Clearance receptors and endopeptidase 24.11: Equal role in natriuretic peptide metabolism in conscious sheep
16. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells
17. Endothelin increases atrial natriuretic peptide production in cultured rat diencephalic neurons
18. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes
19. Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts
20. Angiotensin II-induced atrial natriuretic factor release in dogs is not related to hemodynamic responses
21. A membrane form of guanilate cyclase is an atrial natriuretic peptide receptor
22. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs
23. Effect of atrial natriuretic factor on renin secretion, plasma renin and aldosterone in dogs with acute unilateral renal artery constriction
24. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct
25. Atrial natriuretic peptide inhibits angiotenein-stimulated proximal tubular sodium and water reabsorption
26. Physiological studies of the natriuretic peptide family
27. Effects of synthetic atrial natriuretic factor on renal function and renin release
28. Differential effects of atrial natriuretic factor on angiotensin II and adrenocorticotrophin-stimutated aldosterone secretion
29. Atrial natriuretic polypeptide in the brain: Implication of central cardiovascular control
30. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain
31. Atriopeptin-immunoreactive neurons in the brain: Presence in cardiovascular regulatory areas
32. Hemodynamic and hormonal effects of atrial natriuretic factor in patients with essential hypertension
33. Atrial natriuretic factor in normal subjects and heart failure patients: Plasma levels and renal, hormonal and hemodynamic responses to peptide infusion
34. Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function
35. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure electrolyte homeostasis
36. Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria
37. Atrial natriuretic factor: A hormone produced by the heart
38. Atrial natriuretic factor and its role in circulatory physiology
39. Hemodynamic responses to atrial natriuretic factor in nephrectomized rabbits: Attenuation of the circulatory consequences of acute volume expansion
40. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle
41. Cardiovascular effects of synthetic atrial natriuretic factor in anesthetized and conscious dogs
42. Effect of atrial natriuretic factor on blood pressure, renin and aldosterone in Goldblatt hypertension
43. Differing hemodynamic and hormonal effects of human alpha atrial natriuretic peptide in two models of hypertension
44. Influence of volume expansion on hemodynamic effects of atrial natriuretic factor in rabbits
45. Converting enzyme inhibition prevents the effects of atrial natriuretic factor on baroreflex responses in humans
46. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity
47. Atrial natriuretic factor potentiates forearm reflex vasoconstriction induced by cardiopulmonary receptor deactivation in man
48. Atrial natriuretic peptide and the baroreflex control of circulation
49. Vagal mediation of the effects of atrial natriuretic factor on blood pressure and arterial baroreflexes in the rabbit
50. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells
51. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth
52. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism
53. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes
54. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts
55. Natriuretic peptide receptors of type A in human neuroblastomas
56. Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells
57. Atrial natriuretic peptide elevation in congestive heart failure in the human
58. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart
59. Hormonal profile in mild heart failure
60. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure
61. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism
62. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure
63. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure
64. Regulation of cardiac gene expression during myocardial growth and hypertrephy: Molecular studies of an adaptive physiologic response
65. Cardiac hypertrophy: Sorting out the circuitry
66. Correlates of plasma atrial natriuretic factor in health and hypertension
67. Atrial natriuretic peptides in essential hypertension: Basal plasma levels and relationship to sodium balance
68. Dysregulation of atrial natriuretic factor in hypertension-prone man
69. Atrial natriuretic factor in spontaneously hypertensive rats: Concentration changes with the progression of hypertension and elevated formation of cyclic GMP
70. Cardiovascular actions of ANF: Contributions of renal, neurohumoral, and hemodynamic factors in sheep
71. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man
72. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
73. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes
74. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide
75. A new polymorphic restriction site of the human atrial natriuretic peptide (hANP) gene locus
76. Investigation of the polymorphic Sca I site by a PCR-based assay at the human atrial natriuretic peptide (hANP) gene locus
77. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension
78. Hpall polymorphism of the atrial natriuretic peptide gene and essential hypertension in whites
79. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension
80. Atrial natriuretic peptide gene polymorphism is not associated with essential hypertension: Evidence of association with ethnic origin
81. No effect on blood pressure level or variability of polymorphisms in DNA at the locus for atrial natriuretic factor
82. Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma
83. Chromosomal mapping of quantitative trait loci contributing to stroke in an animal model of complex human disease
84. Altered structure, regulation and function of the gene encoding atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat
85. A differential brain atrial natriuretic peptide expression co-segregates with occurrence of early stroke in the stroke-prone phenotype of spontaneously hypertensive rat
86. Functional relevance of a regulatory mutation of the rat atrial natriuretic peptide gene
87. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke
88. The gene encoding atrial natriuretic peptide and the risk of human stroke
89. Vasopeptidase inhibition: A new concept in blood pressure management
90. Drugs inhibiting the metabolism and inactivation of atrial natriuretic factor. Pharmacological actions and therapeutic implications
91. Renal, endocrine and hemodynamic effects of human brain natriuretic peptide in normal man
92. Actions of C-type natriuretic peptide in isolated canine arteries and veins
93. C-type natriuretic peptide inhibits intimal thickening after vascular injury
94. C-type natriuretic peptide: A selective cardiovascular peptide
95. Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy
96. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction
97. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene